FDA's device center prioritizes postmarket studies

05/29/2008 | FDAnews

The FDA may require device makers to conduct more postmarket surveillance studies under Section 522 of the FDA Amendments Act as the CDRH prioritizes postmarket issues over premarket issues, said Don St. Pierre, a CDRH official.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health